Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 FY- Text added to 2021 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
acalabrutinib, Agenda, AKT, analog, Appellate, atezolizumab, Athena, Australia, balstilimab, Baseline, batch, bevacizumab, BeyondSpring, BIDMC, Bilinsky, Biomedicine, bioreactor, bona, cabozantinib, chemo, comprise, condensed, constantly, constitutionality, core, corroborated, CR, CRO, Daiichi, datopotamab, demographic, deruxtecan, differentiated, double, Eisai, encode, ernst, escalation, ESMO, expiry, feeder, fide, filtered, fit, Genmab, genomic, GRIT, harnessing, headquarter, heterogeneity, histology, ibrutinib, ICI, iCTC, ID, Igor, IL, immunomodulatory, Immunopharma, inactivated, inactivation, incubated, insertion, intolerance, invoicing, judgement, KSQ, lab, lessor, levatinib, Lyell, lymph, MCC, mechanism, MIA, Mirati, mission, multiforme, nearby, neoadjuvant, Neogene, Neoleukin, Nonqualified, Notably, Obsidian, oderparepvec, oncolytic, overhead, parent, path, pattern, Plymouth, portrayal, ransomware, rejuvenate, relatlimab, rep, Replimune, reprioritization, sanction, sanctioning, Sankyo, Sanofi, Seitter, signaling, Simplifying, sitravatinib, slowly, spectrum, static, strain, suggest, Surgery, systematic, temporally, thereon, tier, TILT, tisotumab, TIVDAK, TLR, transformational, Turnstone, vibostolimab, visit, vusolimogene, Weiser, Werewolf, workforce, zalifrelimab, Zeneca
Removed:
AppTec, attaching, attestation, broken, capitalization, Chairman, committing, compensated, consult, controlled, costlier, cytolytic, deeming, defamation, denying, desist, disclosing, dismissed, disqualify, effecting, elimination, Excision, existence, explicitly, Extraction, feasible, Fischkoff, foot, Foundation, ineligible, Integrated, introduce, masthercell, MD, meaningfully, Northern, NY, offshore, Phil, possessing, prejudgment, prorated, purportedly, randomized, reevaluated, reincorporation, remission, repatriated, repatriation, repealing, rescission, restraining, retained, retrospective, software, stipulation, struck, sublease, taxation, Teradata, tolerate, transcription, UNAUDITED, unchanged, unconstitutional, unregistered, untimely, urelumab, validate, Vice
Valuein 2020 FY filing- Value in 2021 FY filing
Original filings
Filing view